{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:34:28Z","timestamp":1790699668061,"version":"4.1.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T00:00:00Z","timestamp":1777939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001230","name":"Macquarie University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001230","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The Intranasal route provides an effective pathway for insulin delivery to the brain compared to oral\/subcutaneous routes as it provides direct access to the brain, bypassing the restrictive blood-brain barrier (BBB), while minimizing systemic exposure. The present study investigated the potential of a thermoresponsive polymer, PNPHO, as a nanocarrier for brain-targeted insulin delivery through the intranasal route, with the aim of repurposing insulin for Alzheimer\u2019s disease treatment. Insulin-loaded nanoparticles (NP) were formulated using an advanced crossflow mixing technology with lower (F1) and higher (F2) PNPHO concentrations and characterised in vitro for size, zeta potential, encapsulation efficiencies, stability, drug deposition, and transport and in vivo for biodistribution. Both F1 and F2 NP demonstrated particle sizes ranging from 35.9 to 49.8\u00a0nm with low polydispersity index (&lt;\u20090.3), negative surface charges, high encapsulation efficiencies (&gt;\u200999%), and conserved structural integrity post 4 weeks of stability study. NP demonstrated significantly greater in vitro nasal deposition compared to insulin alone. Notably, the PNPHO nanocarrier protected insulin from enzymatic degradation, overcoming a key barrier associated with protein\/peptide delivery. In vitro drug transport studies showed an initial delay in NP transport across nasal cells due to PNPHO-mucoadhesive properties, followed by increased transport. Significantly enhanced time-dependent NP transport across the BBB cells compared to insulin alone (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.0001) confirmed NP\u2019s ability to cross the BBB. In vivo, NP demonstrated prolonged nasal retention and higher brain: serum ratio in mice, suggesting sustained drug release and improved brain delivery compared to insulin alone. Collectively, the study highlight the potential of PNPHO as a promising nanocarrier for achieving targeted and efficient intranasal delivery of insulin to the brain.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1007\/s13346-026-02146-1","type":"journal-article","created":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T17:48:47Z","timestamp":1778003327000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Repurposing insulin for Alzheimer\u2019s disease treatment: intranasal delivery of a thermoresponsive nanocarrier-based insulin formulation to the brain"],"prefix":"10.1007","author":[{"given":"Tanisha Tabassum Sayka","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun Yuen Jerry","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zara","family":"Sheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Fathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simin","family":"Maleknia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshad","family":"Oveissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Will","family":"Knox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"van der Hoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abi","family":"Antonito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maree","family":"Svolos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Suman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"Tietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui Xin","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Traini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,5]]},"reference":[{"issue":"7","key":"2146_CR1","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1007\/s13346-024-01558-1","volume":"14","author":"CYJ Wong","year":"2024","unstructured":"Wong CYJ, Baldelli A, Hoyos CM, et al. Insulin Delivery to the Brain via the Nasal Route: Unraveling the Potential for Alzheimer\u2019s Disease Therapy. Drug Deliv Transl Res. 2024;14(7):1776\u201393.","journal-title":"Drug Deliv Transl Res"},{"issue":"9","key":"2146_CR2","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.3390\/pharmaceutics14091870","volume":"14","author":"W Alabsi","year":"2022","unstructured":"Alabsi W, Eedara BB, Encinas-Basurto D, et al. Nose-to-Brain Delivery of Therapeutic Peptides as Nasal Aerosols. Pharmaceutics. 2022;14(9):1870.","journal-title":"Pharmaceutics"},{"issue":"7","key":"2146_CR3","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1080\/17425247.2024.2387110","volume":"21","author":"TTS Khan","year":"2024","unstructured":"Khan TTS, Sheikh Z, Maleknia S, et al. Intranasal delivery of glucagon-like peptide-1 to the brain for obesity treatment: opportunities and challenges. Expert Opin Drug Deliv. 2024;21(7):1081\u2013101.","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"2146_CR4","doi-asserted-by":"publisher","first-page":"17641","DOI":"10.1038\/s41598-018-36210-9","volume":"8","author":"N Kamei","year":"2018","unstructured":"Kamei N, Okada N, Ikeda T, et al. Effective nose-to-brain delivery of exendin-4 via coadministration with cell-penetrating peptides for improving progressive cognitive dysfunction. Sci Rep. 2018;8(1):17641.","journal-title":"Sci Rep"},{"issue":"3","key":"2146_CR5","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1124\/jpet.119.258152","volume":"370","author":"Z Wang","year":"2019","unstructured":"Wang Z, Xiong G, Tsang WC, et al. Nose-to-Brain Delivery. J Pharmacol Exp Ther. 2019;370(3):593\u2013601.","journal-title":"J Pharmacol Exp Ther"},{"issue":"12","key":"2146_CR6","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.3390\/cells12121643","volume":"12","author":"LB De Martini","year":"2023","unstructured":"De Martini LB, Sulmona C, Brambilla L, et al. Cell-Penetrating Peptides as Valuable Tools for Nose-to-Brain Delivery of Biological Drugs. Cells. 2023;12(12):1643.","journal-title":"Cells"},{"key":"2146_CR7","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.jconrel.2024.01.053","volume":"367","author":"D Xu","year":"2024","unstructured":"Xu D, Song XJ, Chen X, et al. Advances and future perspectives of intranasal drug delivery: A scientometric review. J Control Release. 2024;367:366\u201384.","journal-title":"J Control Release"},{"issue":"2","key":"2146_CR8","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1080\/02652048.2022.2051626","volume":"39","author":"C Zuglianello","year":"2022","unstructured":"Zuglianello C, Lemos-Senna E. The nanotechnological approach for nasal delivery of peptide drugs: a comprehensive review. J Microencapsul. 2022;39(2):156\u201375.","journal-title":"J Microencapsul"},{"key":"2146_CR9","doi-asserted-by":"publisher","first-page":"1068495","DOI":"10.3389\/fphar.2022.1068495","volume":"13","author":"J Maeng","year":"2022","unstructured":"Maeng J, Lee K. Systemic and brain delivery of antidiabetic peptides through nasal administration using cell-penetrating peptides. Front Pharmacol. 2022;13:1068495.","journal-title":"Front Pharmacol"},{"issue":"6","key":"2146_CR10","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.cell.2025.01.017","volume":"188","author":"H Shen","year":"2025","unstructured":"Shen H, Aggarwal N, Cui B, et al. Engineered commensals for targeted nose-to-brain drug delivery. Cell. 2025;188(6):1545\u201362. e16.","journal-title":"Cell"},{"issue":"3","key":"2146_CR11","doi-asserted-by":"publisher","first-page":"e70123","DOI":"10.1002\/trc2.70123","volume":"11","author":"KKS Sai","year":"2025","unstructured":"Sai KKS, Erichsen JM, Gollapelli KK, et al. First-in-human positron emission tomography study of intranasal insulin in aging and MCI. Alzheimers Dement (N Y). 2025;11(3):e70123.","journal-title":"Alzheimers Dement (N Y)"},{"issue":"8","key":"2146_CR12","first-page":"e17219","volume":"13","author":"M Gaddam","year":"2021","unstructured":"Gaddam M, Singh A, Jain N, et al. A Comprehensive Review of Intranasal Insulin and Its Effect on the Cognitive Function of Diabetics. Cureus. 2021;13(8):e17219.","journal-title":"Cureus"},{"issue":"4","key":"2146_CR13","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1208\/s12248-015-9719-7","volume":"17","author":"ME Meredith","year":"2015","unstructured":"Meredith ME, Salameh TS, Banks WA. Intranasal Delivery of Proteins and Peptides in the Treatment of Neurodegenerative Diseases. AAPS J. 2015;17(4):780\u20137.","journal-title":"AAPS J"},{"issue":"11","key":"2146_CR14","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.3390\/biom13111568","volume":"13","author":"X Zhou","year":"2023","unstructured":"Zhou X, Kumar P, Bhuyan DJ, et al. Neuroinflammation in Alzheimer\u2019s Disease: A Potential Role of Nose-Picking in Pathogen Entry via the Olfactory System? Biomolecules. 2023;13(11):1568.","journal-title":"Biomolecules"},{"key":"2146_CR15","doi-asserted-by":"publisher","first-page":"104707","DOI":"10.1016\/j.neuint.2020.104707","volume":"135","author":"A Akhtar","year":"2020","unstructured":"Akhtar A, Sah SP. Insulin signaling pathway and related molecules: Role in neurodegeneration and Alzheimer\u2019s disease. Neurochem Int. 2020;135:104707.","journal-title":"Neurochem Int"},{"issue":"7","key":"2146_CR16","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.4239\/wjd.v15.i7.1430","volume":"15","author":"MMI Abdalla","year":"2024","unstructured":"Abdalla MMI. Insulin resistance as the molecular link between diabetes and Alzheimer\u2019s disease. World J Diabetes. 2024;15(7):1430\u201347.","journal-title":"World J Diabetes"},{"key":"2146_CR17","doi-asserted-by":"publisher","first-page":"105907","DOI":"10.1016\/j.neubiorev.2024.105907","volume":"167","author":"A Tabassum","year":"2024","unstructured":"Tabassum A, Badulescu S, Singh E, et al. Central effects of acute intranasal insulin on neuroimaging, cognitive, and behavioural outcomes: A systematic review. Neurosci Biobehav Rev. 2024;167:105907.","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"2146_CR18","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1038\/s41598-019-39191-5","volume":"9","author":"JJ Lochhead","year":"2019","unstructured":"Lochhead JJ, Kellohen KL, Ronaldson PT, et al. Distribution of insulin in trigeminal nerve and brain after intranasal administration. Sci Rep. 2019;9(1):2621.","journal-title":"Sci Rep"},{"key":"2146_CR19","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jconrel.2017.11.040","volume":"270","author":"P Picone","year":"2018","unstructured":"Picone P, Sabatino MA, Ditta LA, et al. Nose-to-brain delivery of insulin enhanced by a nanogel carrier. J Control Release. 2018;270:23\u201336.","journal-title":"J Control Release"},{"issue":"3","key":"2146_CR20","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.2337\/db14-1000","volume":"64","author":"H Zhang","year":"2015","unstructured":"Zhang H, Hao Y, Manor B, et al. Intranasal insulin enhanced resting-state functional connectivity of hippocampal regions in type 2 diabetes. Diabetes. 2015;64(3):1025\u201334.","journal-title":"Diabetes"},{"issue":"3","key":"2146_CR21","doi-asserted-by":"publisher","first-page":"751","DOI":"10.2337\/dc13-1672","volume":"37","author":"V Novak","year":"2014","unstructured":"Novak V, Milberg W, Hao Y, et al. Enhancement of vasoreactivity and cognition by intranasal insulin in type 2 diabetes. Diabetes Care. 2014;37(3):751\u20139.","journal-title":"Diabetes Care"},{"issue":"9","key":"2146_CR22","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1001\/jamaneurol.2020.1840","volume":"77","author":"S Craft","year":"2020","unstructured":"Craft S, Raman R, Chow TW, et al. Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial. JAMA Neurol. 2020;77(9):1099\u2013109.","journal-title":"JAMA Neurol"},{"issue":"7","key":"2146_CR23","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s40263-013-0076-8","volume":"27","author":"J Freiherr","year":"2013","unstructured":"Freiherr J, Hallschmid M, Frey WH 2, et al. Intranasal insulin as a treatment for Alzheimer\u2019s disease: a review of basic research and clinical evidence. CNS Drugs. 2013;27(7):505\u201314.","journal-title":"CNS Drugs"},{"issue":"1 Suppl","key":"2146_CR24","first-page":"S26","volume":"10","author":"FG De Felice","year":"2014","unstructured":"De Felice FG, Lourenco MV, Ferreira ST. How does brain insulin resistance develop in Alzheimer\u2019s disease? Alzheimers Dement. 2014;10(1 Suppl):S26\u201332.","journal-title":"Alzheimers Dement"},{"issue":"1","key":"2146_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1001\/archneurol.2011.233","volume":"69","author":"S Craft","year":"2012","unstructured":"Craft S, Baker LD, Montine TJ, et al. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol. 2012;69(1):29\u201338.","journal-title":"Arch Neurol"},{"issue":"3","key":"2146_CR26","doi-asserted-by":"publisher","first-page":"897","DOI":"10.3233\/JAD-141791","volume":"44","author":"A Claxton","year":"2015","unstructured":"Claxton A, Baker LD, Hanson A, et al. Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer\u2019s disease dementia. J Alzheimers Dis. 2015;44(3):897\u2013906.","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"2146_CR27","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/S0306-4530(02)00087-2","volume":"28","author":"S Craft","year":"2003","unstructured":"Craft S, Asthana S, Cook DG, et al. Insulin dose-response effects on memory and plasma amyloid precursor protein in Alzheimer\u2019s disease: interactions with apolipoprotein E genotype. Psychoneuroendocrinology. 2003;28(6):809\u201322.","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"2146_CR28","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/sj.npp.1301193","volume":"32","author":"C Benedict","year":"2007","unstructured":"Benedict C, Hallschmid M, Schmitz K, et al. Intranasal insulin improves memory in humans: superiority of insulin aspart. Neuropsychopharmacology. 2007;32(1):239\u201343.","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"2146_CR29","doi-asserted-by":"publisher","first-page":"e12934","DOI":"10.1111\/jne.12934","volume":"33","author":"M Hallschmid","year":"2021","unstructured":"Hallschmid M. Intranasal insulin. J Neuroendocrinol. 2021;33(4):e12934.","journal-title":"J Neuroendocrinol"},{"issue":"13","key":"2146_CR30","doi-asserted-by":"publisher","first-page":"e33657","DOI":"10.1016\/j.heliyon.2024.e33657","volume":"10","author":"CM Muntu","year":"2024","unstructured":"Muntu CM, Avanti C, Hayun, et al. Promising brain biodistribution of insulin via intranasal dry powder for nose-to-brain delivery. Heliyon. 2024;10(13):e33657.","journal-title":"Heliyon"},{"issue":"1","key":"2146_CR31","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1038\/s41598-022-05165-3","volume":"12","author":"D Kellar","year":"2022","unstructured":"Kellar D, Register T, Lockhart SN, et al. Intranasal insulin modulates cerebrospinal fluid markers of neuroinflammation in mild cognitive impairment and Alzheimer\u2019s disease: a randomized trial. Sci Rep. 2022;12(1):1346.","journal-title":"Sci Rep"},{"issue":"8","key":"2146_CR32","doi-asserted-by":"publisher","first-page":"6507","DOI":"10.1007\/s12035-016-0169-8","volume":"54","author":"N Rajasekar","year":"2017","unstructured":"Rajasekar N, Nath C, Hanif K, et al. Intranasal Insulin Administration Ameliorates Streptozotocin (ICV)-Induced Insulin Receptor Dysfunction, Neuroinflammation, Amyloidogenesis, and Memory Impairment in Rats. Mol Neurobiol. 2017;54(8):6507\u201322.","journal-title":"Mol Neurobiol"},{"key":"2146_CR33","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.jconrel.2018.12.023","volume":"294","author":"NA Kim","year":"2019","unstructured":"Kim NA, Thapa R, Jeong SH, et al. Enhanced intranasal insulin delivery by formulations and tumor protein-derived protein transduction domain as an absorption enhancer. J Control Release. 2019;294:226\u201336.","journal-title":"J Control Release"},{"issue":"5","key":"2146_CR34","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3109\/10717544.2012.746401","volume":"20","author":"T Nema","year":"2013","unstructured":"Nema T, Jain A, Jain A, et al. Insulin delivery through nasal route using thiolated microspheres. Drug Deliv. 2013;20(5):210\u20135.","journal-title":"Drug Deliv"},{"issue":"8","key":"2146_CR35","doi-asserted-by":"publisher","first-page":"4822","DOI":"10.3390\/app13084822","volume":"13","author":"C Kirby-Smith","year":"2023","unstructured":"Kirby-Smith C, Steenekamp J, Steyn D, et al. Intranasal Insulin Delivery: Microparticle Formulations Consisting of Aloe vera Polysaccharides for Advanced Delivery across Excised Olfactory and Respiratory Nasal Epithelial Tissues. Appl Sci. 2023;13(8):4822.","journal-title":"Appl Sci"},{"issue":"11\u201312","key":"2146_CR36","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.drudis.2010.03.011","volume":"15","author":"X Duan","year":"2010","unstructured":"Duan X, Mao S. New strategies to improve the intranasal absorption of insulin. Drug Discov Today. 2010;15(11\u201312):416\u201327.","journal-title":"Drug Discov Today"},{"key":"2146_CR37","doi-asserted-by":"publisher","first-page":"107070","DOI":"10.1016\/j.jddst.2025.107070","volume":"110","author":"TTS Khan","year":"2025","unstructured":"Khan TTS, Sheikh Z, Fathi A, et al. Exploring intranasal delivery of peptide and protein nanoparticles by a thermoresponsive hydrogel. J Drug Deliv Sci Technol. 2025;110:107070.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"4","key":"2146_CR38","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1021\/acschemneuro.7b00434","volume":"9","author":"MT Nedelcovych","year":"2018","unstructured":"Nedelcovych MT, Gadiano AJ, Wu Y, et al. Pharmacokinetics of Intranasal versus Subcutaneous Insulin in the Mouse. ACS Chem Neurosci. 2018;9(4):809\u201316.","journal-title":"ACS Chem Neurosci"},{"issue":"8","key":"2146_CR39","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1080\/03639045.2020.1788061","volume":"46","author":"CY Wong","year":"2020","unstructured":"Wong CY, Martinez J, Zhao J, et al. Development of orally administered insulin-loaded polymeric-oligonucleotide nanoparticles: statistical optimization and physicochemical characterization. Drug Dev Ind Pharm. 2020;46(8):1238\u201352.","journal-title":"Drug Dev Ind Pharm"},{"issue":"2","key":"2146_CR40","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s10787-024-01636-3","volume":"33","author":"K Komal","year":"2025","unstructured":"Komal K, Ghosh R, Sil D, et al. Advancements in nose-to-brain drug targeting for Alzheimer\u2019s disease: a review of nanocarriers and clinical insights. Inflammopharmacology. 2025;33(2):605\u201326.","journal-title":"Inflammopharmacology"},{"issue":"5","key":"2146_CR41","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1016\/j.apsb.2022.07.003","volume":"13","author":"R Awad","year":"2023","unstructured":"Awad R, Avital A, Sosnik A. Polymeric nanocarriers for nose-to-brain drug delivery in neurodegenerative diseases and neurodevelopmental disorders. Acta Pharm Sin B. 2023;13(5):1866\u201386.","journal-title":"Acta Pharm Sin B"},{"issue":"3","key":"2146_CR42","doi-asserted-by":"publisher","first-page":"797","DOI":"10.4161\/hv.27449","volume":"10","author":"A Smith","year":"2014","unstructured":"Smith A, Perelman M, Hinchcliffe M. Chitosan: a promising safe and immune-enhancing adjuvant for intranasal vaccines. Hum Vaccin Immunother. 2014;10(3):797\u2013807.","journal-title":"Hum Vaccin Immunother"},{"issue":"44","key":"2146_CR43","doi-asserted-by":"publisher","first-page":"5997","DOI":"10.1016\/j.vaccine.2015.07.101","volume":"33","author":"Y Xia","year":"2015","unstructured":"Xia Y, Fan Q, Hao D, et al. Chitosan-based mucosal adjuvants: Sunrise on the ocean. Vaccine. 2015;33(44):5997\u20136010.","journal-title":"Vaccine"},{"issue":"1","key":"2146_CR44","doi-asserted-by":"publisher","first-page":"FSO225","DOI":"10.4155\/fsoa-2017-0064","volume":"4","author":"D Fong","year":"2018","unstructured":"Fong D, Hoemann CD. Chitosan immunomodulatory properties: perspectives on the impact of structural properties and dosage. Future Sci OA. 2018;4(1):FSO225.","journal-title":"Future Sci OA"},{"issue":"6","key":"2146_CR45","doi-asserted-by":"publisher","first-page":"2400356","DOI":"10.1002\/mame.202400356","volume":"310","author":"L Qian","year":"2025","unstructured":"Qian L, Cook MT, Dreiss CA. Situ Gels for Nasal Delivery: Formulation, Characterization and Applications. Macromol Mater Eng. 2025;310(6):2400356.","journal-title":"Macromol Mater Eng"},{"key":"2146_CR46","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jmbbm.2015.10.026","volume":"55","author":"SB De Souza Ferreira","year":"2015","unstructured":"De Souza Ferreira SB, Moco TD, Borghi-Pangoni FB, et al. Rheological, mucoadhesive and textural properties of thermoresponsive polymer blends for biomedical applications. J Mech Behav Biomed Mater. 2015;55:164\u201378.","journal-title":"J Mech Behav Biomed Mater"},{"issue":"Pt 1","key":"2146_CR47","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.msec.2016.09.081","volume":"70","author":"MA Haq","year":"2017","unstructured":"Haq MA, Su Y, Wang D. Mechanical properties of PNIPAM based hydrogels: A review. Mater Sci Eng C Mater Biol Appl. 2017;70(Pt 1):842\u201355.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"2146_CR48","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.ijbiomac.2020.11.047","volume":"167","author":"D Gadhave","year":"2021","unstructured":"Gadhave D, Rasal N, Sonawane R, et al. Nose-to-brain delivery of teriflunomide-loaded lipid-based carbopol-gellan gum nanogel for glioma: Pharmacological and in vitro cytotoxicity studies. Int J Biol Macromol. 2021;167:906\u201320.","journal-title":"Int J Biol Macromol"},{"issue":"21","key":"2146_CR49","doi-asserted-by":"publisher","first-page":"5425","DOI":"10.1016\/j.biomaterials.2014.03.026","volume":"35","author":"A Fathi","year":"2014","unstructured":"Fathi A, Mithieux SM, Wei H, et al. Elastin based cell-laden injectable hydrogels with tunable gelation, mechanical and biodegradation properties. Biomaterials. 2014;35(21):5425\u201335.","journal-title":"Biomaterials"},{"issue":"23","key":"2146_CR50","doi-asserted-by":"publisher","first-page":"e2201714","DOI":"10.1002\/adhm.202201714","volume":"11","author":"D Calder","year":"2022","unstructured":"Calder D, Fathi A, Oveissi F, et al. Thermoresponsive and Injectable Hydrogel for Tissue Agnostic Regeneration. Adv Healthc Mater. 2022;11(23):e2201714.","journal-title":"Adv Healthc Mater"},{"issue":"12","key":"2146_CR51","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/jpp\/rgae122","volume":"76","author":"M Hussain","year":"2024","unstructured":"Hussain M, Binici B, O\u2019Connor L, et al. Production of mRNA lipid nanoparticles using advanced crossflow micromixing. J Pharm Pharmacol. 2024;76(12):1572\u201383.","journal-title":"J Pharm Pharmacol"},{"issue":"8","key":"2146_CR52","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1021\/acs.molpharmaceut.1c00366","volume":"18","author":"AR Clementino","year":"2021","unstructured":"Clementino AR, Pellegrini G, Banella S, et al. Structure and Fate of Nanoparticles Designed for the Nasal Delivery of Poorly Soluble Drugs. Mol Pharm. 2021;18(8):3132\u201346.","journal-title":"Mol Pharm"},{"key":"2146_CR53","doi-asserted-by":"publisher","first-page":"122667","DOI":"10.1016\/j.ijpharm.2023.122667","volume":"635","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Wong CYJ, Gholizadeh H, et al. Microfluidics assembly of inhalable liposomal ciprofloxacin characterised by an innovative in vitro pulmonary model. Int J Pharm. 2023;635:122667.","journal-title":"Int J Pharm"},{"issue":"4","key":"2146_CR54","doi-asserted-by":"publisher","first-page":"e1308","DOI":"10.1002\/lio2.1308","volume":"9","author":"Y Guo","year":"2024","unstructured":"Guo Y, Tang Y, Su Y, et al. Influencing factors of particle deposition in the human nasal cavity. Laryngoscope Investig Otolaryngol. 2024;9(4):e1308.","journal-title":"Laryngoscope Investig Otolaryngol"},{"key":"2146_CR55","doi-asserted-by":"publisher","first-page":"104848","DOI":"10.1016\/j.jddst.2023.104848","volume":"87","author":"A Baldelli","year":"2023","unstructured":"Baldelli A, Wong C, Oguzlu H, et al. Impact of amino acids on the properties of nasal dry powders. J Drug Deliv Sci Technol. 2023;87:104848.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"18","key":"2146_CR56","doi-asserted-by":"publisher","first-page":"6745","DOI":"10.1021\/acs.analchem.2c00160","volume":"94","author":"DD Vallejo","year":"2022","unstructured":"Vallejo DD, Jeon CK, Parson KF, et al. Ion Mobility\u2013Mass Spectrometry Reveals the Structures and Stabilities of Biotherapeutic Antibody Aggregates. Anal Chem. 2022;94(18):6745\u201353.","journal-title":"Anal Chem"},{"issue":"1","key":"2146_CR57","doi-asserted-by":"publisher","first-page":"7672","DOI":"10.1038\/s41598-024-58317-y","volume":"14","author":"S Tan","year":"2024","unstructured":"Tan S, Gu Y, Zhu Y, et al. Insights from bioinformatics analysis reveal that lipopolysaccharide induces activation of chemokine-related signaling pathways in human nasal epithelial cells. Sci Rep. 2024;14(1):7672.","journal-title":"Sci Rep"},{"key":"2146_CR58","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ejpb.2016.07.010","volume":"107","author":"M Pozzoli","year":"2016","unstructured":"Pozzoli M, Ong HX, Morgan L, et al. Application of RPMI 2650 nasal cell model to a 3D printed apparatus for the testing of drug deposition and permeation of nasal products. Eur J Pharm Biopharm. 2016;107:223\u201333.","journal-title":"Eur J Pharm Biopharm"},{"issue":"7","key":"2146_CR59","doi-asserted-by":"publisher","first-page":"103795","DOI":"10.1016\/j.xphs.2025.103795","volume":"114","author":"CYJ Wong","year":"2025","unstructured":"Wong CYJ, Leite E, Ong HX, et al. Intranasal delivery of temozolomide and desloratadine for brain tumour therapy: A cellular study on nasal epithelial toxicity, transport, and permeability. J Pharm Sci. 2025;114(7):103795.","journal-title":"J Pharm Sci"},{"issue":"4","key":"2146_CR60","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.apsb.2021.02.012","volume":"11","author":"CP Costa","year":"2021","unstructured":"Costa CP, Moreira JN, Sousa Lobo JM, et al. Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: A current overview of in vivo studies. Acta Pharm Sinica B. 2021;11(4):925\u201340.","journal-title":"Acta Pharm Sinica B"},{"key":"2146_CR61","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ejpb.2023.06.015","volume":"189","author":"CYJ Wong","year":"2023","unstructured":"Wong CYJ, Baldelli A, Gholizadeh H, et al. Engineered dry powders for the nose-to-brain delivery of transforming growth factor-beta. Eur J Pharm Biopharm. 2023;189:202\u201311.","journal-title":"Eur J Pharm Biopharm"},{"issue":"24","key":"2146_CR62","doi-asserted-by":"publisher","first-page":"13258","DOI":"10.3390\/ijms222413258","volume":"22","author":"H Akel","year":"2021","unstructured":"Akel H, Csoka I, Ambrus R, et al. In Vitro Comparative Study of Solid Lipid and PLGA Nanoparticles Designed to Facilitate Nose-to-Brain Delivery of Insulin. Int J Mol Sci. 2021;22(24):13258.","journal-title":"Int J Mol Sci"},{"key":"2146_CR63","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.jconrel.2020.07.044","volume":"327","author":"M Agrawal","year":"2020","unstructured":"Agrawal M, Saraf S, Saraf S, et al. Stimuli-responsive In situ gelling system for nose-to-brain drug delivery. J Controlled Release. 2020;327:235\u201365.","journal-title":"J Controlled Release"},{"issue":"1","key":"2146_CR64","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3109\/10717544.2013.849778","volume":"21","author":"UC Galgatte","year":"2014","unstructured":"Galgatte UC, Kumbhar AB, Chaudhari PD. Development of in situ gel for nasal delivery: design, optimization, in vitro and in vivo evaluation. Drug Deliv. 2014;21(1):62\u201373.","journal-title":"Drug Deliv"},{"issue":"45","key":"2146_CR65","doi-asserted-by":"publisher","first-page":"13379","DOI":"10.1021\/acs.langmuir.1c02056","volume":"37","author":"DJ Pochapski","year":"2021","unstructured":"Pochapski DJ, Carvalho Dos Santos C, Leite GW, et al. Zeta Potential and Colloidal Stability Predictions for Inorganic Nanoparticle Dispersions: Effects of Experimental Conditions and Electrokinetic Models on the Interpretation of Results. Langmuir. 2021;37(45):13379\u201389.","journal-title":"Langmuir"},{"issue":"1","key":"2146_CR66","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12943-025-02410-x","volume":"24","author":"P Kesharwani","year":"2025","unstructured":"Kesharwani P, Kumar V, Goh KW, et al. PEGylated PLGA nanoparticles: unlocking advanced strategies for cancer therapy. Mol Cancer. 2025;24(1):205.","journal-title":"Mol Cancer"},{"key":"2146_CR67","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.2147\/IJN.S439181","volume":"19","author":"J Koo","year":"2024","unstructured":"Koo J, Lim C, Oh KT. Recent Advances in Intranasal Administration for Brain-Targeting Delivery: A Comprehensive Review of Lipid-Based Nanoparticles and Stimuli-Responsive Gel Formulations. Int J Nanomed. 2024;19:1767\u2013807.","journal-title":"Int J Nanomed"},{"key":"2146_CR68","doi-asserted-by":"publisher","first-page":"114046","DOI":"10.1016\/j.jconrel.2025.114046","volume":"386","author":"Y Zheng","year":"2025","unstructured":"Zheng Y, Kuang L, Lu C, et al. Naturally derived mucoadhesive nanosuspension for treatment of multiple staged ocular infections. J Control Release. 2025;386:114046.","journal-title":"J Control Release"},{"issue":"1","key":"2146_CR69","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1089\/jamp.2013.1093","volume":"28","author":"K Inthavong","year":"2015","unstructured":"Inthavong K, Fung MC, Yang W, et al. Measurements of droplet size distribution and analysis of nasal spray atomization from different actuation pressure. J Aerosol Med Pulm Drug Deliv. 2015;28(1):59\u201367.","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"issue":"2","key":"2146_CR70","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3390\/pharmaceutics6020195","volume":"6","author":"S Trows","year":"2014","unstructured":"Trows S, Wuchner K, Spycher R, et al. Analytical challenges and regulatory requirements for nasal drug products in europe and the u.s. Pharmaceutics. 2014;6(2):195\u2013219.","journal-title":"Pharmaceutics"},{"key":"2146_CR71","doi-asserted-by":"publisher","first-page":"125506","DOI":"10.1016\/j.ijpharm.2025.125506","volume":"676","author":"A Rajbanshi","year":"2025","unstructured":"Rajbanshi A, Hilton E, Atkinson E, et al. Thermoresponsive engineered emulsions stabilised with branched copolymer surfactants for nasal drug delivery of molecular therapeutics. Int J Pharm. 2025;676:125506.","journal-title":"Int J Pharm"},{"key":"2146_CR72","doi-asserted-by":"crossref","unstructured":"Gondhale-Karpe P, Bhope S, Puri M, Manwatkar S, Mahajan B. Analytical Tools for the Characterization of Nasal Spray Drug Products. Springer nature; 2024.","DOI":"10.1007\/978-981-97-2596-0_4"},{"issue":"7","key":"2146_CR73","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/jps.20090","volume":"93","author":"P Dayal","year":"2004","unstructured":"Dayal P, Shaik MS, Singh M. Evaluation of different parameters that affect droplet-size distribution from nasal sprays using the Malvern Spraytec. J Pharm Sci. 2004;93(7):1725\u201342.","journal-title":"J Pharm Sci"},{"issue":"6","key":"2146_CR74","doi-asserted-by":"publisher","first-page":"2902","DOI":"10.1021\/acs.chemrev.2c00600","volume":"123","author":"E Christofi","year":"2023","unstructured":"Christofi E, Barran P. Ion Mobility Mass Spectrometry (IM-MS) for Structural Biology: Insights Gained by Measuring Mass, Charge, and Collision Cross Section. Chem Rev. 2023;123(6):2902\u201349.","journal-title":"Chem Rev"},{"issue":"1","key":"2146_CR75","doi-asserted-by":"publisher","first-page":"21894","DOI":"10.1038\/s41598-021-01216-3","volume":"11","author":"WJ Kim","year":"2021","unstructured":"Kim WJ, Kwon YJ, Cho CH, et al. Insulin smart drug delivery nanoparticles of aminophenylboronic acid-POSS molecule at neutral pH. Sci Rep. 2021;11(1):21894.","journal-title":"Sci Rep"},{"issue":"5","key":"2146_CR76","doi-asserted-by":"publisher","first-page":"675","DOI":"10.3390\/biom10050675","volume":"10","author":"M Amaral","year":"2020","unstructured":"Amaral M, Martins AS, Catarino J, et al. How Can Biomolecules Improve Mucoadhesion of Oral Insulin? A Comprehensive Insight using Ex-Vivo, In Silico, and In Vivo Models. Biomolecules. 2020;10(5):675.","journal-title":"Biomolecules"},{"issue":"5","key":"2146_CR77","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1021\/acs.biomac.3c00102","volume":"24","author":"A di Costagliola","year":"2023","unstructured":"di Costagliola A, Baghbantarghdari Z, De Gregorio V, et al. Insulin Activation Mediated by Uptake Mechanisms: A Comparison of the Behavior between Polymer Nanoparticles and Extracellular Vesicles in 3D Liver Tissues. Biomacromolecules. 2023;24(5):2203\u201312.","journal-title":"Biomacromolecules"},{"issue":"28","key":"2146_CR78","doi-asserted-by":"publisher","first-page":"24757","DOI":"10.1021\/acsomega.2c02747","volume":"7","author":"Q Zheng","year":"2022","unstructured":"Zheng Q, Lee B, Kebede MT, et al. Exchange Broadening Underlies the Enhancement of IDE-Dependent Degradation of Insulin by Anionic Membranes. ACS Omega. 2022;7(28):24757\u201365.","journal-title":"ACS Omega"},{"issue":"2","key":"2146_CR79","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jcis.2010.07.072","volume":"351","author":"Z Sideratou","year":"2010","unstructured":"Sideratou Z, Sterioti N, Tsiourvas D, et al. Arginine end-functionalized poly(L-lysine) dendrigrafts for the stabilization and controlled release of insulin. J Colloid Interface Sci. 2010;351(2):433\u201341.","journal-title":"J Colloid Interface Sci"},{"issue":"2","key":"2146_CR80","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3109\/10717544.2014.916769","volume":"23","author":"NH Patil","year":"2016","unstructured":"Patil NH, Devarajan PV. Insulin-loaded alginic acid nanoparticles for sublingual delivery. Drug Deliv. 2016;23(2):429\u201336.","journal-title":"Drug Deliv"},{"issue":"8","key":"2146_CR81","doi-asserted-by":"publisher","first-page":"711","DOI":"10.3390\/ph14080711","volume":"14","author":"CP Costa","year":"2021","unstructured":"Costa CP, Barreiro S, Moreira JN, et al. Vitro Studies on Nasal Formulations of Nanostructured Lipid Carriers (NLC) and Solid Lipid Nanoparticles (SLN). Pharmaceuticals (Basel). 2021;14(8):711.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"2146_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1023\/A:1018911206646","volume":"9","author":"MA Sarkar","year":"1992","unstructured":"Sarkar MA. Drug metabolism in the nasal mucosa. Pharm Res. 1992;9(1):1\u20139.","journal-title":"Pharm Res"},{"key":"2146_CR83","doi-asserted-by":"publisher","first-page":"121068","DOI":"10.1016\/j.ijpharm.2021.121068","volume":"608","author":"J Dholakia","year":"2021","unstructured":"Dholakia J, Prabhakar B, Shende P. Strategies for the delivery of antidiabetic drugs via intranasal route. Int J Pharm. 2021;608:121068.","journal-title":"Int J Pharm"},{"issue":"11","key":"2146_CR84","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.3390\/cells10112941","volume":"10","author":"J Mett","year":"2021","unstructured":"Mett J, Lauer AA, Janitschke D, et al. Medium-Chain Length Fatty Acids Enhance Abeta Degradation by Affecting Insulin-Degrading Enzyme. Cells. 2021;10(11):2941.","journal-title":"Cells"},{"issue":"10","key":"2146_CR85","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.3390\/biom13101492","volume":"13","author":"GR Tundo","year":"2023","unstructured":"Tundo GR, Grasso G, Persico M, et al. The Insulin-Degrading Enzyme from Structure to Allosteric Modulation: New Perspectives for Drug Design. Biomolecules. 2023;13(10):1492.","journal-title":"Biomolecules"},{"issue":"16","key":"2146_CR86","doi-asserted-by":"publisher","first-page":"18309","DOI":"10.1021\/acsanm.3c03807","volume":"7","author":"ME VanLandingham","year":"2024","unstructured":"VanLandingham ME, Heintz RA, Kariyawasam CS, et al. Ionic-Liquid-Modified Nanoparticles as Potential Mucus Modulators for Nasal Drug Delivery. ACS Appl Nano Mater. 2024;7(16):18309\u201317.","journal-title":"ACS Appl Nano Mater"},{"issue":"1","key":"2146_CR87","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1038\/s41598-018-19930-w","volume":"8","author":"Y Rai","year":"2018","unstructured":"Rai Y, Pathak R, Kumari N, et al. Mitochondrial biogenesis and metabolic hyperactivation limits the application of MTT assay in the estimation of radiation induced growth inhibition. Sci Rep. 2018;8(1):1531.","journal-title":"Sci Rep"},{"issue":"9","key":"2146_CR88","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1016\/j.xphs.2017.04.036","volume":"106","author":"S Ito","year":"2017","unstructured":"Ito S, Yanai M, Yamaguchi S, et al. Regulation of Tight-Junction Integrity by Insulin in an In Vitro Model of Human Blood-Brain Barrier. J Pharm Sci. 2017;106(9):2599\u2013605.","journal-title":"J Pharm Sci"},{"issue":"1","key":"2146_CR89","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1080\/10717544.2018.1464081","volume":"25","author":"HD Bae","year":"2018","unstructured":"Bae HD, Lee J, Jun KY, et al. Modification of translationally controlled tumor protein-derived protein transduction domain for improved intranasal delivery of insulin. Drug Deliv. 2018;25(1):1025\u201332.","journal-title":"Drug Deliv"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02146-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-026-02146-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-026-02146-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T09:02:46Z","timestamp":1778058166000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-026-02146-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":89,"alternative-id":["2146"],"URL":"https:\/\/doi.org\/10.1007\/s13346-026-02146-1","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,5]]},"assertion":[{"value":"1 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were conducted following ethical guidelines approved by the Animal Ethics Committee of Macquarie University. All procedures in live mice were performed according to and by approved personnel listed on the Animal Research Authority (AEC reference number 2021\/007) and complied with the statement on animal experimentation issued by the National Health and Medical Research Council (NHMRC) of Australia.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}